Skip to main content

Articles

Practice Management
Value-Based Agreements in Healthcare: Willingness versus Ability
Gary Branning, MBA; Michael Lynch, CPA, MBA; Kathryn Hayes
Read More
Review Article, Practice Management
Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present
Cori Gray, PharmD; Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM; Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP
Stakeholder Perspective
Successes and Challenges of the Medicare Part D MTM Program
Jack E. Fincham, PhD, RPh
Read More
Lung Cancer, Oncology
Repotrectinib, an Investigational TKI, Elicits Responses in Patients with Advanced NSCLC and ROS1 Alterations
Wayne Kuznar
Read More
Leukemia, Oncology
Gilteritinib and CX-01 in the Treatment of Patients with Acute Myeloid Leukemia
Phoebe Starr
Read More
In the Literature, Oncology
Long-Term Outcomes Affect Cost-Effectiveness of CAR T-­Cell Therapy for DLBCL
Read More
In the Literature, Oncology
Alpelisib Prolongs Progression-Free Survival in Advanced Breast Cancer with PIK3CA Mutation
Read More
In the Literature, Oncology
New Triple-Drug Regimen for Newly Diagnosed Patients with Multiple Myeloma
Read More
Leukemia, Oncology
Fixed-Duration Targeted Therapy with Venetoclax plus Obinutuzumab New Front-Line Standard for Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Read More
Biomarkers, Oncology
Larotrectinib Has Wide-Ranging Efficacy in Advanced Solid Tumors with NTRK Gene Fusion
Wayne Kuznar
Read More
Cholangiocarcinoma, Oncology
Expanding Treatment Options for Patients with Advanced Cholangiocarcinoma
Wayne Kuznar
Read More
Page 46 of 244
Results 451 - 460 of 2436